Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNCT, X-ray, and Temozolomide for Newly Diagnosed Glioblastoma
NCT00974987Phase 2Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Sep 2009
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium borocaptate, borofalan in glioblastoma multiforme (GBM), sponsored by Translational Research Center for Medical Innovation. Started Sep 2009; status: completed.
02
Drugs
sodium borocaptateborofalan
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00974987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974987.